References
- Amato, M., et al., 2010. Visceral Adiposity Index: a reliable indicator of visceral fat functionassociated with cardiometabolic risk. Diabetes care, 33 (4), 920–922.
- Arancibia, C., et al., 2014. Evaluation of serum insulin levels after an oral glucose load for the diagnosis of insulin resistance. Revista Médica de Chile, 142 (9), 1106–1112.
- Ascaso, J., et al., 2003. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes care, 26 (12), 3320–3325.
- Ascaso, J.F., et al., 2001. Insulin resistance quantification by fasting insulid plasma values and HOMA index in non diabetic population. Medicina Clínica, 117, 530–533.
- Bello-Chavolla, O.Y., et al., 2018. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. European journal of endocrinology, 178 (5), 533–544.
- Boden, G., 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 46, 3–10.
- Brahimaj, A., et al., 2019. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia, 62 (9), 1581–1590.
- Chen, C., et al., 2014. The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China. Lipids in health and disease, 13 (1), 108.
- Conroy, R.M., et al., 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projects. European heart journal, 24 (11), 987–1003.
- Dobiasova, M. and Frohlich, J., 2001. The plasma parameterlog (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size andesterification rate in apoB-lipoprotein-depletedplasma (FER(HDL)). Clinical biochemistry, 34, 583–588.
- European Society of Cardiology., 2019. SCORE Risk charts. Available from: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts [accessed 25 September 2019].
- Fantuzzi, G. and Mazzone, T., 2007. Adipose tissue and atherosclerosis: exploring the connection. Arteriosclerosis, thrombosis, and vascular biology, 27, 996–1003.
- Freemantle, N., et al., 2008. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? International journal of clinical practice, 62 (9), 1391–1396.
- Gateva, A. and Kamenov, Z., 2012. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. European journal of obstetrics & gynecology and reproductive biology, 164 (2), 161–166.
- Gomez-Marcos, M., et al., 2019. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study). PLoS One, 14 (1), e0209992.
- Hadaegh, F., Shafiee, G., and Azizi, F., 2009. Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women. Annals of Saudi medicine, 29 (3), 194–200.
- Kahn, H.S. and Valdez, R., 2003. Metabolic risks identified bythe combination of enlarged waist and elevatedtriacylglycerol concentration. The American journal of clinical nutrition, 78 (5), 928–934.
- Kissebah, A.H., et al., 1982. Relation of body fat distribution to metabolic complications of obesity. Journal of clinical endocrinology and metabolism, 54, 254–260.
- Kissebah, A.H. and Krakower, G.R., 1994. Regional adiposity and morbidity. Physiological reviews, 74, 761–811.
- Kouli, G., et al., 2017. Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutrition, metabolism and cardiovascular diseases, 27 (10), 881–889.
- Krakauer, N.Y. and Krakauer, J.C., 2012. A new body shape indexpredicts mortality hazard independently of bodymass index. PLoS one, 7, e39504.
- Krakauer, N.Y. and Krakauer, J.C., 2016. An anthropometric risk index based on combining height, weight, waist, and hip measurements. Journal of obesity, 2016, 8094275.
- Krotkiewski, M., et al., 1983. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. Journal of clinical investigation, 72, 1150–1162.
- Nusrianto, R., et al., 2019. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: the Bogor cohort study of non-communicable diseases risk factors. Diabetes research and clinical practice, 155, 107798.
- Ohlson, L.O., et al., 1985. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes, 34 (10), 1055–1058.
- Park, Y., et al., 2018. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Scientific reports, 8 (1), 16753.
- Piepoli, M.F., Hoes, A.W., and Agewall, S., 2016. European guidelines on cardiovascular disease prevention in clinical practice. European heart journal, 37 (29), 2315–2381.
- Poirier, P., et al., 2006. Obesity and cardiovascular disease: pathophysiology, evaluation and effect of weight loss. Circulation, 113, 898–918.
- Saely, C., et al., 2018. The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes. Diabetes, 67 (1), 2091.
- Thomas, D.M., et al., 2013. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity, 21 (11), 2264–2271.
- Wei, J., et al., 2019. Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients, 11 (7), 1580.